Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Frates James M
Relationship:  
City:   Cambridge
State:   MA
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   318,827    

Indirect Shares

  184,010      
Direct Value   $2,148,775    

Indirect Value

  $3,642,655      
Total Shares   502,837      
Total Value   $5,791,430      


Alkermes Plc
 $2,148,775 Sage Therapeutics, Inc.
 $0 Amylyx Pharmaceuticals, Inc.
 $0 Alkermes Plc
 $2,148,775 Sage Therapeutics, Inc.
 $0 Amylyx Pharmaceuticals, Inc.
 $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Alkermes Plc ALKS SVP, Alks Inc; CFO ALKS 2020-05-14 91,828 2020-05-14 155,669    Premium*  
            Sage Therapeutics, Inc. SAGE 2021-06-16 1,035 2021-06-16 1,810    Premium*  
            Amylyx Pharmaceuticals, Inc. AMLX 2024-04-16 225,964 2024-04-16 26,531    Premium*  
* Premium Members only  

Records found :    262         Free Registration Required For Full Results.    Limit: 25

Download
  Page 9 of 11
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
ALKS Alkermes Plc SVP, Alks Inc; CFO ALKS   •       •      –    2017-05-28 4 OE $0.00 $0 D/D 2,500 130,654 0 -
ALKS Alkermes Plc SVP, Alks Inc; CFO ALKS   •       •      –    2017-06-09 4 GD $0.00 $0 D/D 2,000 127,477 0 -
ALKS Alkermes Plc SVP, Alks Inc; CFO ALKS   •       •      –    2017-11-08 4 OE $12.29 $257,254 D/D 20,932 164,971 0 -
ALKS Alkermes Plc SVP, Alks Inc; CFO ALKS   •       •      –    2017-11-08 4 AS $47.58 $996,009 D/D (20,932) 144,039 0 -
ALKS Alkermes Plc SVP, Alks Inc; CFO ALKS   •       •      –    2017-11-29 4 AS $50.49 $1,057,249 D/D (20,932) 144,039 0 -
ALKS Alkermes Plc SVP, Alks Inc; CFO ALKS   •       •      –    2017-11-29 4 OE $12.29 $257,254 D/D 20,932 164,971 0 -
ALKS Alkermes Plc SVP, Alks Inc; CFO ALKS   •       •      –    2017-12-15 4 GD $0.00 $0 D/D 2,000 38,256 0 -
ALKS Alkermes Plc SVP, Alks Inc; CFO ALKS   •       •      –    2018-02-17 4 OE $0.00 $0 D/D 3,000 147,039 0 -
ALKS Alkermes Plc SVP, Alks Inc; CFO ALKS   •       •      –    2018-02-17 4 D $67.26 $62,485 D/D (929) 146,110 0 -
ALKS Alkermes Plc SVP, Alks Inc; CFO ALKS   •       •      –    2018-03-01 4 OE $0.00 $0 D/D 4,500 83,882 0 -
ALKS Alkermes Plc SVP, Alks Inc; CFO ALKS   •       •      –    2018-03-01 4 D $57.41 $76,126 D/D (1,326) 82,556 0 -
ALKS Alkermes Plc SVP, Alks Inc; CFO ALKS   •       •      –    2018-03-03 4 D $60.05 $61,791 D/D (1,029) 84,340 0 -
ALKS Alkermes Plc SVP, Alks Inc; CFO ALKS   •       •      –    2018-03-03 4 OE $0.00 $0 D/D 2,813 85,369 0 -
SAGE Sage Therapeutics, Inc.   –       •      –    2018-05-08 4 OE $8.92 $62,440 D/D 7,000 12,000 0 -
SAGE Sage Therapeutics, Inc.   –       •      –    2018-05-08 4 AS $154.00 $1,078,000 D/D (7,000) 5,000 0 -
ALKS Alkermes Plc SVP, Alks Inc; CFO ALKS   •       •      –    2018-06-12 4 AS $50.00 $842,179 D/D (16,842) 37,234 0 -
SAGE Sage Therapeutics, Inc.   –       •      –    2018-08-22 4 GD $0.00 $0 D/D 765 4,235 0 -
ALKS Alkermes Plc SVP, Alks Inc; CFO ALKS   •       •      –    2018-12-07 4 D $34.01 $83,154 D/D (2,445) 40,289 0 -
ALKS Alkermes Plc SVP, Alks Inc; CFO ALKS   •       •      –    2018-12-07 4 A $0.00 $0 D/D 5,500 42,734 0 -
SAGE Sage Therapeutics, Inc.   –       •      –    2019-01-23 4 OE $8.92 $66,900 D/D 7,500 11,735 0 -
SAGE Sage Therapeutics, Inc.   –       •      –    2019-01-23 4 AS $134.81 $1,011,075 D/D (7,500) 4,235 0 -
ALKS Alkermes Plc SVP, Alks Inc; CFO ALKS   •       •      –    2019-02-16 4 D $32.54 $35,729 D/D (1,098) 42,566 0 -
ALKS Alkermes Plc SVP, Alks Inc; CFO ALKS   •       •      –    2019-02-16 4 OE $0.00 $0 D/D 3,375 43,664 0 -
ALKS Alkermes Plc SVP, Alks Inc; CFO ALKS   •       •      –    2019-02-17 4 OE $0.00 $0 D/D 3,000 45,566 0 -
ALKS Alkermes Plc SVP, Alks Inc; CFO ALKS   •       •      –    2019-02-17 4 D $32.54 $28,473 D/D (875) 44,691 0 -

  262  Records found
  1   2   3   4   5   6   7   8   9  10   11      
  Page 9 of 11  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed